TNMG
TNL Mediagene Ordinary SharesNASDAQCOMMUNICATION SERVICESPUBLISHING
Key Statistics
Market Cap
$2.17M
P/E Ratio
—
EPS
$-56.72
Beta
1.41
52W High
$26.40
52W Low
$0.80
50-Day MA
$1.97
200-Day MA
$4.95
Dividend Yield
—
Profit Margin
-167.90%
Forward P/E
—
PEG Ratio
—
About TNL Mediagene Ordinary Shares
TNL Mediagene Ordinary Shares is a forward-thinking biopharmaceutical company dedicated to the development and commercialization of cutting-edge medical therapies aimed at addressing significant unmet medical needs, particularly in the fields of oncology and autoimmune disorders. With a robust pipeline leveraging advanced technologies and strategic partnerships, the company is well-positioned for substantial growth in the dynamic healthcare landscape. TNL Mediagene's unwavering commitment to scientific research and innovative approaches underpins its mission to improve patient outcomes, establishing it as a prominent entity in the biopharmaceutical industry.
Fundamentals
| Revenue (TTM) | $49.67M |
| Gross Profit (TTM) | $16.54M |
| EBITDA | $-47.96M |
| Operating Margin | -25.90% |
| Return on Equity | -164.60% |
| Return on Assets | -31.70% |
| Revenue/Share (TTM) | $37.81 |
| Book Value | $13.64 |
| Price-to-Book | 0.06 |
| Price-to-Sales (TTM) | 0.04 |
| EV/Revenue | 0.355 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 5.70% |
| Shares Outstanding | $2.56M |
| Float | $2.12M |
| % Insiders | 19.49% |
| % Institutions | 6.83% |
Historical Volatility
HV 10-Day
106.86%
HV 20-Day
150.00%
HV 30-Day
136.19%
HV 60-Day
117.52%
HV Rank
—
Volatility is currently contracting
More COMMUNICATION SERVICES Stocks
Data last updated: 5/2/2026